<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04661046</url>
  </required_header>
  <id_info>
    <org_study_id>SHSLCZDZK 03701</org_study_id>
    <nct_id>NCT04661046</nct_id>
  </id_info>
  <brief_title>Study on the Correlation Between Gene Mutation and TCM Syndrome Types in Metastatic Colorectal Cancer</brief_title>
  <official_title>Study on the Correlation Between Gene Mutation and TCM Syndrome Types in Metastatic Colorectal Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai University of Traditional Chinese Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shanghai University of Traditional Chinese Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To explore the correlation between gene mutations of metastatic colorectal cancer and TCM&#xD;
      syndrome types based on Second-generation sequencing technology.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 30, 2020</start_date>
  <completion_date type="Anticipated">August 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Overall Survival</measure>
    <time_frame>2 years</time_frame>
    <description>OS</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Progression Free Survival</measure>
    <time_frame>2 years</time_frame>
    <description>PFS</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Gene Mutation-Related Cancer</condition>
  <condition>Traditional Chinese Medicine</condition>
  <arm_group>
    <arm_group_label>TCM Syndrome Types</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Traditional Chinese Medicine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Traditional Chinese Medicine</intervention_name>
    <description>Chinese medicine prescription</description>
    <arm_group_label>TCM Syndrome Types</arm_group_label>
    <other_name>TCM</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. A clear pathological diagnosis is a patient with colorectal cancer;&#xD;
&#xD;
          2. Have complete TNM staging information;&#xD;
&#xD;
          3. There is a clear diagnosis of the location and time of metastasis;&#xD;
&#xD;
          4. Age ≥18 years old, ≤80 years old, male or female;&#xD;
&#xD;
          5. There is a clear time for the first treatment with Chinese medicine;&#xD;
&#xD;
          6. Patients who can receive long-term follow-up. -&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients with colorectal cancer diagnosed pathologically as adenosquamous carcinoma,&#xD;
             squamous cell carcinoma, carcinoid, small cell carcinoma, malignant lymphoma, etc.;&#xD;
&#xD;
          2. Patients with double cancer, multiple or metastatic colorectal cancer;&#xD;
&#xD;
          3. Combined with severe acute and chronic diseases that may affect treatment and&#xD;
             prognosis, such as myocardial infarction, stroke, severe renal insufficiency and&#xD;
             mental illness;-&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>November 20, 2020</study_first_submitted>
  <study_first_submitted_qc>December 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 9, 2020</study_first_posted>
  <last_update_submitted>December 8, 2020</last_update_submitted>
  <last_update_submitted_qc>December 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

